跳至主要内容
临床试验/jRCTs051210021
jRCTs051210021招募中不适用

Investigation of clinical effect of vitamin D supplement therapy for pancreatic cancer

未提供0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
主要终点
Pathological evaluation of the number of alfa-SMA positive cells in resected pancreatic cancer specimens

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • (1) Patients with confirmed pancreatic cancer classified as resectable pancreatic cancer who are scheduled to undergo surgery in 4 to 8 weeks after 5 to 8 weeks of preoperative systemic chemotherapy or chemoradiation.
  • (2) Age at the time of consent: 20 years or older
  • (3) PS: 0-1 (ECOG grade)
  • (4) Patients with major organ function (bone marrow, liver, kidney, lung, etc.)
  • White blood cell count: 3,500/mm3 or higher, neutrophil count: 2,000/mm3 or higher,
  • platelet count: 100,000/mm3 or higher.
  • Hemoglobin: 9.0 g/dL or higher
  • Total bilirubin: 2.0 mg/dL or less (However, 3.0 mg/dL or less for patients undergoing biliary drainage for obstructive jaundice caused by tumor)
  • AST(GOT), ALT(GPT): 150U/L or less
  • Serum creatinine level: 1.2 mg/dL or less, creatinine clearance: 60 mL/min or more (estimation by the Cockcroft-Gault formula is acceptable)
  • (5)Patients whose written consent to participate in this study has been obtained.

排除标准

  • (1) Patients with the following electrolyte abnormalities:
  • Hypercalcemia (corrected serum Ca level of 11.5 mg/dl or higher (equivalent to Grade 2 in CTCAE ver4.0))
  • Hyper PTH, PTHrPemia (above the standard value)
  • (2) Patients who are using or have taken drugs, supplements, or health foods related to bone metabolism (bisphosphonate, vitamin D, calcium, phosphorus, etc.)
  • (3) Patients who are using steroids
  • (4) Patients who have difficulty with oral treatment
  • (5) Patients with severe mental disorders
  • (6) Patients with severe drug hypersensitivity
  • (7) Patients with pregnant or wishing to pregnant
  • (8) Other patients who are judged by the principal investigator or sub-investigator to be inappropriate for the safe conduct of this study.

结局指标

主要结局

Pathological evaluation of the number of alfa-SMA positive cells in resected pancreatic cancer specimens

Number of alfa-SMA positive cells in five randomly selected fields of view at 200x in stromal cells in pancreatic cancer tissue

次要结局

  • Relationship between alfa-SMA positive cells and Vitamin D administration period
  • Relationship between alfa-SMA positive cells and Serum vitamin D concentration
  • Relationship between alfa-SMA positive cells and Background factors
  • Rate of change in bone mineral density
  • Adverse events

研究者

发起方
未提供

相似试验